DE NOVELLIS, DANILO
 Distribuzione geografica
Continente #
AS - Asia 1.361
NA - Nord America 515
EU - Europa 453
SA - Sud America 91
AF - Africa 22
OC - Oceania 1
Totale 2.443
Nazione #
HK - Hong Kong 802
US - Stati Uniti d'America 494
SG - Singapore 277
DE - Germania 136
CN - Cina 94
RU - Federazione Russa 88
VN - Vietnam 80
BR - Brasile 68
IT - Italia 63
FI - Finlandia 60
IN - India 29
ES - Italia 23
FR - Francia 21
BD - Bangladesh 16
KR - Corea 15
GB - Regno Unito 14
AR - Argentina 13
AT - Austria 12
CZ - Repubblica Ceca 11
CA - Canada 10
JP - Giappone 10
ZA - Sudafrica 9
MX - Messico 6
NL - Olanda 6
PK - Pakistan 6
PL - Polonia 6
IQ - Iraq 5
MA - Marocco 5
TR - Turchia 5
CO - Colombia 4
EC - Ecuador 4
ID - Indonesia 4
IE - Irlanda 3
SE - Svezia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
HN - Honduras 2
MD - Moldavia 2
MY - Malesia 2
PH - Filippine 2
TN - Tunisia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BE - Belgio 1
BH - Bahrain 1
BZ - Belize 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MM - Myanmar 1
NG - Nigeria 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
SN - Senegal 1
VE - Venezuela 1
Totale 2.443
Città #
Hong Kong 800
San Jose 144
Singapore 135
Munich 116
Ashburn 56
Helsinki 43
Dallas 35
Council Bluffs 28
Ho Chi Minh City 23
Beijing 21
Valencia 20
Lauterbourg 18
New York 17
Hanoi 16
Los Angeles 16
Nuremberg 16
Orem 13
Moscow 11
Rome 10
Santa Clara 10
Brno 9
Milan 9
São Paulo 8
The Dalles 8
Salerno 7
Buffalo 6
Chennai 6
Denver 6
Johannesburg 6
Montreal 6
Tokyo 6
Turku 6
Warsaw 6
Yancheng 6
Amsterdam 5
Da Nang 5
Haiphong 5
Hải Dương 5
Jyväskylä 5
West Jordan 5
Atlanta 4
Frankfurt am Main 4
Houston 4
Seoul 4
Vienna 4
Biên Hòa 3
Boardman 3
Brasília 3
Dublin 3
Fort Worth 3
Kolkata 3
Krasnodar 3
Lahore 3
Lappeenranta 3
London 3
Mumbai 3
Nagoya 3
Nellore 3
Phoenix 3
Piacenza 3
Seattle 3
Shanghai 3
Stockholm 3
Baghdad 2
Baku 2
Belo Horizonte 2
Bologna 2
Boston 2
Can Tho 2
Cape Town 2
Cardiff 2
Chicago 2
Corato 2
Hamilton 2
Istanbul 2
Juiz de Fora 2
Londrina 2
Manchester 2
Medellín 2
Milwaukee 2
Mosul 2
Muğla 2
Plano 2
Poplar 2
Porto Alegre 2
Quito 2
Rio de Janeiro 2
San Bernardino 2
Sidoarjo 2
St Petersburg 2
Tashkent 2
Turin 2
Abuja 1
Alcamo 1
Amman 1
Ankara 1
Aracaju 1
Azrou 1
Barueri 1
Batavia 1
Totale 1.813
Nome #
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 494
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies 309
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 217
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 197
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 100
CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience 88
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 85
A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A 83
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients 82
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 79
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience 77
SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE 77
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition 74
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience 73
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients 71
Multiple myeloma characteristics correlated to serum free light chain ratio at diagnosis and association with early renal damage 69
Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience 67
Efficacy of Daratumumab-Based Regimens for Extramedullary Pulmonary Plasmacytoma: A Case Report 66
Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance 55
Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review 53
Prolonged Hematogone Expansion Is Associated with Better Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients 34
Plasma Elastase Screening in Hematological Disease Reveals Its Potential as a Diagnostic and Prognostic Biomarker in Hematological Malignancies 8
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study 8
Next generation sequencing reveals spatio-temporal clonal heterogeneity in an aggressive relapsed/refractory multiple myeloma case 3
Multiple myeloma patients treated with lenalidomide-based regimens frequently experience delayed peripheral blood stem cell collection: A controlled real-life study 1
Totale 2.470
Categoria #
all - tutte 7.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.283


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202315 0 0 0 0 1 3 5 1 2 0 3 0
2023/2024114 11 10 9 9 6 16 6 4 3 4 15 21
2024/2025489 17 11 9 14 26 50 137 50 88 22 29 36
2025/20261.852 58 425 474 119 188 68 160 35 105 150 54 16
Totale 2.470